HA121-28

· CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HA121-28, covering 2022-08-04 to 2022-08-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of HA121-28 in Patients With Non-Small Cell Lung Cancer [Phase 2]